ZenoWell Debuts BrainCLOS at 2026 Clinical & Health Psychology Conference

Date: March 30, 2026 | Location: Shenzhen, China

From March 27 to 28, 2026, the "14th Conference for Chinese Psychologists & Academic Conference on Clinical and Health Psychology", hosted by the School of Humanities and Social Science at The Chinese University of Hong Kong, Shenzhen (CUHK-Shenzhen), concluded successfully. The conference focused on "Challenges and Opportunities for Chinese Psychologists in the Fourth Industrial Revolution," gathering global leaders in neuroscience and psychology.

As a pioneer in neuromodulation and mental health technology, ZenoWell is proud to have sponsored this prestigious event, marking our first major offline academic appearance of 2026.

ZenoWell team showcasing BrainCLOS closed-loop VNS system at CUHK-Shenzhen Psychology Conference 2026

BrainCLOS: A Breakthrough in Research-Grade Closed-Loop VNS

At the ZenoWell booth, our team showcased our latest research-grade innovation: the BrainCLOS Closed-Loop Vagus Nerve Stimulation (VNS) System.

While traditional transcutaneous auricular vagus nerve stimulation (taVNS) often relies on static, open-loop parameters, BrainCLOS introduces a sophisticated biofeedback mechanism that bridges the gap between research and clinical application. During technical exchanges with senior psychologists, we highlighted three core research dimensions:

  1. Respiratory-Gated VNS (rVNS): The system captures the subject’s respiratory waveform in real-time, triggering stimulation only during specific phases of the breathing cycle to maximize vagal activation using natural physiological rhythms.

  2. HRV Closed-Loop Regulation: By monitoring Heart Rate Variability (HRV) in real-time, BrainCLOS dynamically adjusts stimulation intensity based on the individual's immediate autonomic state, offering a personalized approach to stress management.

  3. Synergy with Psychological Interventions: We explored how synchronized neuromodulation during Cognitive Behavioral Therapy (CBT) can enhance neuroplasticity, significantly improving long-term therapeutic outcomes.

BrainCLOS research-grade closed-loop vagus nerve stimulation device with HRV and respiratory gating feedback

AI Agent: A New Paradigm for Research and Product Application

In alignment with the "Fourth Industrial Revolution" theme, ZenoWell engaged in deep discussions regarding the demand and value of AI Agents in psychology.

The consensus among experts is that AI Agents are no longer just automation tools but the core of future mental health management. By utilizing AI to process the large-scale physiological data streams collected by BrainCLOS, we can achieve:

  • Precision Physiological Profiling: Identifying subtle physiological responses under varying psychological stressors.

  • Intelligent Digital Companions: AI Agents acting as "digital mental health advisors," providing real-time, science-backed guidance based on neuromodulation data.

ZenoWell neurotechnology experts discussing AI Agents and mental health data analysis at clinical psychology conference

Moving Forward: A New Journey for Neurotech in 2026

Participating in the CUHK-Shenzhen psychology conference is a vital milestone for ZenoWell in deepening our academic roots and promoting the integration of industry and research. We believe that by combining advanced closed-loop VNS technology with rigorous psychological science, we can deliver more scientifically-backed mental health solutions to users worldwide.


Frequently Asked Questions (FAQ)

Q1: What is the BrainCLOS Closed-Loop VNS System?

A: BrainCLOS is a research-grade, non-invasive transcutaneous auricular vagus nerve stimulation (taVNS) system developed by ZenoWell. It integrates biofeedback mechanisms to adjust stimulation parameters in real-time based on the user’s breathing and heart rate variability (HRV), achieving precision closed-loop regulation.

Q2: What are the benefits of Respiratory-Gated VNS (rVNS) in psychology?

A: rVNS technology triggers nerve stimulation during specific phases of the respiratory cycle (such as exhalation). This synchronization maximizes vagal activation, leading to more significant physiological effects in stress management, anxiety relief, and autonomic nervous system balancing.

Q3: Why introduce AI Agents into neurotechnology?

A: AI Agents can analyze large-scale physiological data streams collected by BrainCLOS. They help researchers create precise psycho-physiological profiles and act as "digital advisors" for users, providing dynamic intervention guidance for personalized health management.

About ZenoWell ZenoWell is a wearable neurotechnology company dedicated to improving human autonomic balance and mental health through industry-leading vagus nerve stimulation (taVNS) technology. Explore more technical details at our Official Website.

Stay Connected For the latest neuroscience insights and product updates, join our professional community on the WhatsApp Channel.

 

Related Posts

ZenoWell Supports the 8th International Neurotechnology Innovation Forum 2026 in Shanghai

Date: April 17–19, 2026Location: Brain Intelligence World International Conference Center, Minbei Road 618, Shanghai, China From April 17 to 19, 2026, the 8th International...
Post by YMay
Apr 17 2026

ZenoWell Announces Strategic Cooperation with USound to Explore Advanced Sensing Technologies for Next-Generation Wearable Devices

25th March 2026 ZenoWell, a wearable neurotechnology company focused on ear-based vagus nerve stimulation solutions, today announced a cooperation with USound, a global leader...
Post by YMay
Mar 25 2026

Supporting Long-Term Care in Chronic Gastrointestinal Health

Event: 3rd Annual Virtual Gastroparesis ConferenceHost: G-PACT (Gastroparesis Patient Association for Cures and Treatments)Date: March 21, 2026Time: 10:00 am – 2:00 pm (EST)Format: Online...
Post by YMay
Mar 06 2026

ZenoWell Founder Presents on Vagus Nerve Regulation and Neurofeedback at ACAN 2026

Date: June 5–6, 2026Location: Opatija, CroatiaEvent: 4th Annual Conference for Applied Neurofeedback (ACAN 2026)Official Conference Website: https://www.acan.beemedic.com/content ZenoWell’s founder was invited to speak at...
Post by YMay
Mar 04 2026

Stanford GMIX Project Group Visit ZenoWell

Date: August 19, 2025 Location: ZenoWell Innovation Center Overview A Stanford GMIX (Global Management Immersion Experience) student group with backgrounds in Biomedical Engineering, Medicine,...
Post by ZenoWellGlobal
Sep 23 2025

ICP 2024 – ZenoWell cofounder Presents Breakthrough Research on ASD and Neuroimaging

Date: July 21 – 26, 2024 Location: O₂ universum,Prague, Czech Republic At the 33rd International Congress of Psychology (ICP 2024), held once every four...
Post by ZenoWellGlobal
Jul 30 2025

CES 2025 – ZenoWell Showcases the Future of Wearable Neurotechnology

Date: January 9–12, 2025 Location: Digital Health Pavilion, CES, Las Vegas Convention Center, Las Vegas, USA ZenoWell made its official debut at CES 2025,...
Post by ZenoWellGlobal
Jul 25 2025